Ultrasound Index Fat Fraction
Not Applicable
Not yet recruiting
- Conditions
- Steatosis of Liver
- Interventions
- Device: Echographic scan
- Registration Number
- NCT06373796
- Lead Sponsor
- SuperSonic Imagine
- Brief Summary
The objective is to compare the ultrasound index fat fraction (FAT PLUS), derived from several ultrasound biomarkers, with the gold-standard imaging exam for liver fat content evaluation (MRI-PDFF) in patients to quantify the hepatic steatosis.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- NOT_YET_RECRUITING
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
- Subject is ≥ 18 years old.
- Subject is able to understand and sign the Informed Consent Form.
- Subject is able to stand and walk independently.
- Subject must have at least one or more routine ultrasound imaging procedures of the abdomen, at one of the participating study sites.
- Subject must have at least one routine liver MRI with PDFF score performed within 30 days before or after the ultrasound examination
- Subject is affiliated to National Social Insurance or a Health Insurance Regimen
Exclusion Criteria
- Subject is unable or unwilling to adhere to Study procedures
- Subject is unable to understand the Informed Consent
- Subject is unable to express its consent
- Subject is under legal protection
- Subject is deprived of liberty by judicial or administrative decision
- Subject undergoes psychiatric treatment under constraint
- Subject is pregnant or breastfeeding
- Subject has latex allergy
- Subject has an open wound, cut, and/or a rash which would preclude an ultrasound imaging procedure
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description FAT PLUS Echographic scan -
- Primary Outcome Measures
Name Time Method FAT PLUS 3 months The objective is to compare the ultrasound index fat fraction (FAT PLUS), derived from several ultrasound biomarkers, with the gold-standard imaging exam for liver fat content evaluation (MRI-PDFF) in patients to quantify the hepatic steatosis.
- Secondary Outcome Measures
Name Time Method